The impact of cytomegalovirus infection on new-onset diabetes mellitus after kidney transplantation: A review on current findings

Journal of Nephropathology

Volumn 3, Issue 4, 2014, Pages 139-148

  Einollahi, Behzad ^a   Motalebi, Mohsen ^a   Salesi, Mahmood ^a   Ebrahimi, Mehrdad ^a   Taghipour, Mehrdad ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytomegalovirus; Kidney transplantation; New onset diabetes

Indexed keywords

EID: 84925080454     PISSN: 22518363     EISSN: 22518819     Source Type: Journal    
DOI: 10.12860/jnp.2014.27     Document Type: Article

References (74)

1. Kesiraju S, Paritala P, Rao Ch UM, Sahariah S. New onset of diabetes after transplantation-An overview of epidemiology, mechanism of development and diagnosis. Transpl Immunol 2014;30(1):52-8.
2. Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S, Olstad M, et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006;69(3):588-95.
3. Pietrzak-Nowacka M, Safranow K, Dziewanowski K, Debska-Slizien A, Glyda M, Golembiewska E, et al. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation. Ann Acad Med Stetin 2008;54(1):41-8.
4. Valderhaug TG, Hjelmesaeth J, Jenssen T, Roislien J, Leivestad T, Hartmann A. Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses. Transplantation 2012;94(7):714-20.
5. Lehr H, Jao S, Waltzer W, Anaise D, Rapaport F, editors. Cytomegalovirus-induced diabetes mellitus in a renal allograft recipient. Transplant Proc 1985.
6. Hjelmesaeth J, Hartmann A, Kofstad J, Stenstrom J, Leivestad T, Egeland T, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997;64(7):979-83.
7. Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, et al. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 2004;47(9):1550-6.
8. Sulanc E, Lane JT, Puumala SE, Groggel GC, Wrenshall LE, Stevens RB. New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. Transplantation 2005;80(7):945-52.
9. Marin M, Renoult E, Bondor C, Kessler M, editors. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. Transplant Proc 2005;37(4):1851-6.
10. Nemati E, Taheri S, Pourfarziani V, Einollahi B. Cytomegalovirus disease in renal transplant recipients: an Iranian experience. Exp Clin Transplant 2008;6(2):132-6.
11. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007;4(10):e296.
12. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152(11):726-32.
13. Yang W-C, Chen Y-S, Hsieh W-C, Shih M-H, Lee M-C. Post-transplant Diabetes Mellitus in Renal Transplant Recipients—Experience in Buddhist Tzu Chi General Hospital. Tzu Chi Med J 2006;18(3):185-91
14. Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Roislien J, Jenssen T, et al. Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade. Transplantation 2007;84(9):1125-30.
15. Madziarska K, Weyde W, Krajewska M, Patrzalek D, Janczak D, Kusztal M, et al. The increased risk of post-transplant diabetes mellitus in peritoneal dialysis-treated kidney allograft recipients. Nephrol Dial Transplant 2011;26(4):1396-401.
16. Numakura K, Satoh S, Tsuchiya N, Horikawa Y, Inoue T, Kakinuma H, et al. Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation 2005;80(10):1419-24.
17. Alberti K, Davidson MB, DeFronzo RA, Drash A, Genuth S, Harris MI, et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care 1998;21:S5.
18. Bodziak KA, Hricik DE. New-onset diabetes mellitus after solid organ transplantation. Transpl Int 2009;22(5):519-30.
19. Ghisdal L, Van Laecke S, Abramowicz MJ, Vanholder R, Abramowicz D. New-onset diabetes after renal transplantation: Risk assessment and management. Diabetes care 2012;35(1):181-8.
20. Guitard J, Rostaing L, Kamar N. New-onset diabetes and nephropathy after renal transplantation. Contrib Nephrol 2011;170:247-55.
21. Hjelmesaeth J, Asberg A, Muller F, Hartmann A, Jenssen T. New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection. Curr Diabetes Rev 2005;1(1):1-10.
22. Hjelmesaeth J, Muller F, Jenssen T, Rollag H, Sagedal S, Hartmann A. Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol Dial Transplant 2005;20(11):2311-5.
23. José Pérez-Sola M, José Castón J, Solana R, Rivero A, Torre-Cisneros J. Indirect effects of cytomegalovirus infection in solid organ transplant recipients. Enferm Infecc Microbiol Clin 2008;26(1):38-47.
24. Pham PT, Pham PM, Pham SV, Pham PA, Pham PC. New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes 2011;4:175-86.
25. Pham PTT, Pham PCT, Lipshutz GS, Wilkinson AH. New Onset Diabetes Mellitus After Solid Organ Transplantation. Endocrinol Metab Clin North Am 2007;36(4):873-90.
26. Rodrigo E, Fernandez-Fresnedo G, Valero R, Ruiz JC, Pinera C, Palomar R, et al. New-onset diabetes after kidney transplantation: risk factors. J Am Soc Nephrol 2006;17(12 Suppl 3):S291-5.
27. Sagedal S, Hartmann A, Rollag H. The impact of early cytomegalovirus infection and disease in renal transplant recipients. Clin Microbiol Infect 2005;11(7):518-30.
28. Türk TR, Witzke O. New-onset diabetes mellitus after kidney transplantation. Der Nephrologe 2011;6(5):428-34.
29. Markell M. New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis 2004;43(6):953-65.
30. Davidson JA, Wilkinson A. New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines An endocrinologist’s view. Diabetes care 2004;27(3):805-12.
31. Leung Ki EL, Venetz JP, Meylan P, Lamoth F, Ruiz J, Pascual M. Cytomegalovirus infection and new-onset post-transplant diabetes mellitus. Clin Transplant 2008;22(2):245-9.
32. Smith RM. CMV prophylaxis: a useful step towards prevention of post-transplant diabetes? Diabetologia 2004;47(9):1473-5.
33. Chan HW, Cheung CY, Liu YL, Chan YH, Wong HS, Chak WL, et al. Prevalence of abnormal glucose metabolism in Chinese renal transplant recipients: A single centre study. Nephrol Dial Transplant 2008;23(10):3337-42.
34. Gourishankar S, Jhangri GS, Tonelli M, Wales LH, Cockfield SM. Development of diabetes mellitus following kidney transplantation: a Canadian experience. Am J Transplant 2004;4(11):1876-82.
35. Sharma RK, Prakash R, Jeloka T, Gupta A, Gulati S, Sharma AP, et al. Posttransplant diabetes mellitus in renal transplant recipients-a single-center experience. Transplant Proc 2003;35(1):266-7.
36. Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, Haider S, et al. Incidence and Cost of New Onset Diabetes Mellitus Among US Wait-Listed and Transplanted Renal Allograft Recipients. Am J Transplant 2003;3(5):590-8.
37. Burroughs TE, Swindle JP, Salvalaggio PR, Lentine KL, Takemoto SK, Bunnapradist S, et al. Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. Transplantation 2009;88(3):367-73.
38. Cole EH, Prasad GV, Cardella CJ, Kim JS, Tinckam KJ, Cattran DC, et al. A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients. Transplant Res 2013;2(1):1.
39. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000;23 (Suppl 1):S4-S19.
40. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S5-20.
41. Consultation WHO. Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1; diagnostic and classification of Diabetes Mellitus 1999.
42. Diagnosis and Classification of Diabetes Mellitus. Diabetes care 2004;27(suppl 1):s5-s10.
43. Fabrizi F, Lampertico P, Lunghi G, Mangano S, Aucella F, Martin P. Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation. Aliment Pharmacol Ther 2005;21(6):623-32.
44. Pak C, Mcarthur R, Eun H-M, Yoon J-W. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 1988;332(8601):1-4.
45. Kamar N, Mariat C, Delahousse M, Dantal J, Al Najjar A, Cassuto E, et al. Diabetes mellitus after kidney transplantation: a French multicentre observational study. Nephrol Dial Transplant 2007;22(7):1986-93.
46. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol J, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007;7(6):1506-14.
47. Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009;68(7):1119-24.
48. Koizumi M, Yada T. Sub-chronic stimulation of glucocorticoid receptor impairs and mineralocorticoid receptor protects cytosolic Ca2+ responses to glucose in pancreatic beta-cells. J Endocrinol 2008;197(2):221-9.
49. Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A. Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy. Diabetes Care 2001;24(12):2121-6.
50. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 2003;18(10):2154-9.
51. Lemieux I, Houde I, Pascot A, Lachance JG, Noel R, Radeau T, et al. Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients. Kidney Int 2002;62(5):1839-47.
52. Boots JM, van Duijnhoven EM, Christiaans MH, Wolffenbuttel BH, van Hooff JP. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 2002;13(1):221-7.
53. Pascual J, Zamora J, Galeano C, Royuela A, Quereda C. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009(1):Cd005632.
54. Lopes P, Fuhrmann A, Sereno J, Pereira MJ, Nunes P, Pedro J, et al. Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model. Transplant Proc 2013;45(3):1142-8.
55. Menegazzo LA, Ursich MJ, Fukui RT, Rocha DM, Silva ME, Ianhez LE, et al. Mechanism of the diabetogenic action of cyclosporin A. Horm Metab Res 1998;30(11):663-7.
56. Dmitrewski J, Krentz AJ, Mayer AD, Buckels JA, Barnes AD, Smith J, et al. Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation. Diabetes Obes Metab 2001;3(4):287-92.
57. Sumrani NB, Delaney V, Ding ZK, Davis R, Daskalakis P, Friedman EA, et al. Diabetes mellitus after renal transplantation in the cyclosporine era--an analysis of risk factors. Transplantation 1991;51(2):343-7.
58. von Kiparski A, Frei D, Uhlschmid G, Largiader F, Binswanger U. Post-transplant diabetes mellitus in renal allograft recipients: a matched-pair control study. Nephrol Dial Transplant 1990;5(3):220-5.
59. Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation 1989;47(2):278-81.
60. Yoshimura N, Nakai I, Ohmori Y, Aikawa I, Fukuda M, Yasumura T, et al. Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 1988;12(1):11-7.
61. Cole EH, Johnston O, Rose CL, Gill JS. Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol 2008;3(3):814-21.
62. Shah T, Kasravi A, Huang E, Hayashi R, Young B, Cho YW, et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 2006;82(12):1673-6.
63. Tamura K, Fujimura T, Tsutsumi T, Nakamura K, Ogawa T, Atumaru C, et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation 1995;59(11):1606-13.
64. Radu RG, Fujimoto S, Mukai E, Takehiro M, Shimono D, Nabe K, et al. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity. Am J Physiol Endocrinol Metab 2005;288(2):E365-E71.
65. Boots JM, van Duijnhoven EM, Christiaans MH, Wolffenbuttel BH, van Hooff JP. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 2002;13(1):221-7.
66. Kesiraju S, Paritala P, Rao Ch UM, Sahariah S. New onset of diabetes after transplantation-an overview of epidemiology, mechanism of development and diagnosis. Transpl Immunol 2014;30(1):52-8.
67. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant 2005;5(10):2433-40.
68. Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005;67(6):2415-21.
69. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42(7):579-89.
70. Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, Kumari M, et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 2010;340:b4838.
71. Hamer RA, Chow CL, Ong AC, McKane WS. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007;83(1):36-40.
72. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci (Lond) 1999;96(5):513-23.
73. Geer EB, Islam J, Buettner C. Mechanisms of Glucocorticoid-Induced Insulin Resistance: Focus on Adipose Tissue Function and Lipid Metabolism. Endocrinol Metab Clin North Am 2014;43(1):75-102.
74. Midtvedt K, Hjelmesæth J, Hartmann A, Lund K, Paulsen D, Egeland T, et al. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004;15(12):3233-9